Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CEST
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; [email protected]

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
Stocks mentioned in the article
ChangeLast1st jan.
CARDINAL HEALTH 0.28% 54.25 Delayed Quote.-11.70%
CVS HEALTH CORPORATION 1.17% 71.6 Delayed Quote.-2.39%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
06/20CVS HEALTH : Expands Safe Drug Disposal at CVS Pharmacy Locations in Arizona to ..
PR
06/20CVS HEALTH : Consumer Watchdog Testifies at Aetna/CVS Merger Hearing; Tells Insu..
AQ
06/20CVS HEALTH : CEO Larry Merlo to Discuss Disruption and Transformation in Health ..
PR
06/20CVS HEALTH : Delivering convenience
AQ
06/19Caterpillar, Facebook and Baidu drop while CVS climbs
AQ
06/19CVS On Pace for Largest One-Day Gain Since December 2015 -- Data Talk
DJ
06/19CVS HEALTH : Recognized as One of The 50 Most Community-Minded Companies by Poin..
PR
06/19CVS HEALTH : Tries to Stay Ahead of Amazon
AQ
06/19CVS HEALTH : will now deliver prescriptions to your home
AQ
06/19CVS HEALTH : Adds Home Delivery With Help From Post Office
DJ
More news
News from SeekingAlpha
06/20SA INTERVIEW : Chris DeMuth Jr. On First United And ETF Reconstitutions 
06/20GE Booted From The Dow, Trump Threatens China Trade War Escalation (Wall Stre.. 
06/20WALL STREET BREAKFAST : General Electric Booted From The DJIA 
06/20CVS launches prescription delivery nationwide 
06/1910 Dividend Growth Stocks For June 2018 
Financials ($)
Sales 2018 189 B
EBIT 2018 9 960 M
Net income 2018 5 331 M
Debt 2018 19 678 M
Yield 2018 2,94%
P/E ratio 2018 14,01
P/E ratio 2019 10,90
EV / Sales 2018 0,49x
EV / Sales 2019 0,45x
Capitalization 71 948 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 86,4 $
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORPORATION-2.39%71 948
WALGREENS BOOTS ALLIANCE-11.03%64 072
EXPRESS SCRIPTS HOLDING CO7.32%45 263
MCKESSON CORPORATION-5.91%29 609
AMERISOURCEBERGEN0.38%20 259
CARDINAL HEALTH-11.70%16 808